These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 32479845)

  • 1. Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery.
    Mašková E; Kubová K; Raimi-Abraham BT; Vllasaliu D; Vohlídalová E; Turánek J; Mašek J
    J Control Release; 2020 Aug; 324():695-727. PubMed ID: 32479845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of Muco-Adhesive Oral Films by the 3D Printing of Hydroxypropyl Methylcellulose-Based Catechin-Loaded Formulations.
    Tagami T; Yoshimura N; Goto E; Noda T; Ozeki T
    Biol Pharm Bull; 2019; 42(11):1898-1905. PubMed ID: 31685772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.
    Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S
    Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amorphous solid dispersion of a binary formulation with felodipine and HPMC for 3D printed floating tablets.
    Mora-Castaño G; Millán-Jiménez M; Niederquell A; Schönenberger M; Shojaie F; Kuentz M; Caraballo I
    Int J Pharm; 2024 Jun; 658():124215. PubMed ID: 38740104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC).
    Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
    AAPS J; 2020 Feb; 22(2):49. PubMed ID: 32072317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties.
    Thakkar R; Zhang Y; Zhang J; Maniruzzaman M
    Eur J Pharm Biopharm; 2021 Jun; 163():141-156. PubMed ID: 33838262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
    Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
    Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lyophilized ophthalmologic patches as novel corneal drug formulations using a semi-solid extrusion 3D printer.
    Tagami T; Goto E; Kida R; Hirose K; Noda T; Ozeki T
    Int J Pharm; 2022 Apr; 617():121448. PubMed ID: 35066116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot-scale binder jet 3D printing of sustained release solid dosage forms.
    Tan M; Dharani D; Dong X; Maiorana C; Chaudhuri B; Nagapudi K; Chang SY; Ma AWK
    Int J Pharm; 2023 Jan; 631():122540. PubMed ID: 36566828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
    Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
    Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biopharmaceutical implications of excipient variability on drug dissolution from immediate release products.
    Zarmpi P; Flanagan T; Meehan E; Mann J; Østergaard J; Fotaki N
    Eur J Pharm Biopharm; 2020 Sep; 154():195-209. PubMed ID: 32681966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A framework to investigate drug release variability arising from hypromellose viscosity specifications in controlled release matrix tablets.
    Mitchell SA; Balwinski KM
    J Pharm Sci; 2008 Jun; 97(6):2277-85. PubMed ID: 17828741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of semi-solid formulations for 3D printing of drugs after prolonged storage to mimic real-life applications.
    Aita IE; Breitkreutz J; Quodbach J
    Eur J Pharm Sci; 2020 Apr; 146():105266. PubMed ID: 32060006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation into the effects of ink formulations of semi-solid extrusion 3D printing on the performance of printed solid dosage forms.
    Zhang B; Belton P; Teoh XY; Gleadall A; Bibb R; Qi S
    J Mater Chem B; 2023 Dec; 12(1):131-144. PubMed ID: 38050731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
    Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
    Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
    Alhijjaj M; Belton P; Qi S
    Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards functional characterization of excipients for oral solid dosage forms using UV-vis imaging. Liberation, release and dissolution.
    Li Z; Sun Y; Bar-Shalom D; Mu H; Larsen SW; Jensen H; Østergaard J
    J Pharm Biomed Anal; 2021 Feb; 194():113789. PubMed ID: 33298380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.